Average Co-Inventor Count = 3.81
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (14 from 1,451 patents)
2. Synthelabo (9 from 252 patents)
3. Sanofi-synthelabo (2 from 152 patents)
4. Sanofi-aventis (1 from 389 patents)
26 patents:
1. 9675606 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
2. 9452164 - Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
3. 9169246 - Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
4. 9150544 - Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
5. 9126972 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
6. 9012413 - FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof
7. 8859544 - Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
8. 8835653 - Chlorothiophene-isoxazoles as inhibitors of coagulation factors Xa and thrombin
9. 8759344 - Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
10. 8623893 - Pyridino-pyridinone derivatives, preparation and therapeutic use thereof
11. 8623862 - [object Object]
12. 8552201 - 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
13. 8436011 - Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof
14. 8378092 - Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombin
15. 8110579 - 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists